Evaluation of the Medidux™ Digital Health Application in Patients With HER2-positive Breast Cancer.

NCT05425550 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
196
Enrollment
INDUSTRY
Sponsor class

Stopped The study was discontinued due to low recruitment rates. Despite various measures, such as training courses and workshops, recruitment rates could not be improved in the long term.

Conditions

Interventions

Sponsor

Palleos Healthcare GmbH

Collaborators